+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Percutaneous Coronary Intervention (PCI) Devices - Global Market Trajectory & Analytics

  • ID: 5140077
  • Report
  • April 2021
  • Region: Global
  • 179 Pages
  • Global Industry Analysts, Inc
Global Percutaneous Coronary Intervention (PCI) Devices Market to Reach $19.1 Billion by 2027

Amid the COVID-19 crisis, the global market for Percutaneous Coronary Intervention (PCI) Devices estimated at US$10.2 Billion in the year 2020, is projected to reach a revised size of US$19.1 Billion by 2027, growing at a CAGR of 9.5% over the analysis period 2020-2027. Coronary Stents, one of the segments analyzed in the report, is projected to record a 10.9% CAGR and reach US$7.4 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the PTCA Catheters segment is readjusted to a revised 8.8% CAGR for the next 7-year period.







The U.S. Market is Estimated at $3 Billion, While China is Forecast to Grow at 8.8% CAGR

The Percutaneous Coronary Intervention (PCI) Devices market in the U.S. is estimated at US$3 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$3.3 Billion by the year 2027 trailing a CAGR of 8.8% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.7% and 7.7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 7.6% CAGR.

Coronary Guidedwires Segment to Record 8.5% CAGR

In the global Coronary Guidedwires segment, USA, Canada, Japan, China and Europe will drive the 8.6% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$1.8 Billion in the year 2020 will reach a projected size of US$3.2 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$2.2 Billion by the year 2027.

Select Competitors (Total 44 Featured):
  • Abbott Laboratories
  • AMG International
  • Asahi Intecc Co., Ltd.
  • B. Braun Melsungen AG
  • Biosensors International Group Ltd.
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • BrosMed Medical Co., Ltd.
  • Claret Medical
  • Comed B.V.
  • Contego Medical, LLC
  • Cordis Corporation
  • Elixir Medical Corporation
  • EPflex Feinwerktechnik GmbH
  • GaltNeedleTech
  • Lepu Mdicial Technology (Beijing) Co., Ltd
  • Medtronic PLC
  • Meril Life Sciences Pvt., Ltd.
  • Merit Medical Systems, Inc.
  • OptiMed Medizinische Instrumente GmbH
  • OrbusNeich
  • Penumbra, Inc.
  • RONTIS
  • SP Medical A/S
  • Stentys SA
  • Teleflex Inc.
  • Terumo Medical Corporation
Frequently Asked Questions about the Global Market for Percutaneous Coronary Intervention (PCI) Devices

What is the estimated value of the Global Market for Percutaneous Coronary Intervention (PCI) Devices?

The Global Market for Percutaneous Coronary Intervention (PCI) Devices was estimated to be valued at $10.2 Billion in 2020.

What is the growth rate of the Global Market for Percutaneous Coronary Intervention (PCI) Devices?

The growth rate of the Global Market for Percutaneous Coronary Intervention (PCI) Devices is 9.4%, with an estimated value of $19.1 Billion by 2027.

What is the forecasted size of the Global Market for Percutaneous Coronary Intervention (PCI) Devices?

The Global Market for Percutaneous Coronary Intervention (PCI) Devices is estimated to be worth $19.1 Billion by 2027.
Note: Product cover images may vary from those shown

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 2: World Historic Review for Percutaneous Coronary Intervention (PCI) Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 3: World 15-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027
  • Table 4: World Current & Future Analysis for Coronary Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 5: World Historic Review for Coronary Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 6: World 15-Year Perspective for Coronary Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
  • Table 7: World Current & Future Analysis for PTCA Catheters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 8: World Historic Review for PTCA Catheters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 9: World 15-Year Perspective for PTCA Catheters by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
  • Table 10: World Current & Future Analysis for Coronary Guidedwires by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 11: World Historic Review for Coronary Guidedwires by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 12: World 15-Year Perspective for Coronary Guidedwires by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
  • Table 13: World Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 14: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 15: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
  • Table 16: World Current & Future Analysis for Ambulatory Surgical Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 17: World Historic Review for Ambulatory Surgical Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 18: World 15-Year Perspective for Ambulatory Surgical Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
  • Table 19: World Current & Future Analysis for Catheterization Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 20: World Historic Review for Catheterization Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 21: World 15-Year Perspective for Catheterization Labs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027

III. MARKET ANALYSIS
  • UNITED STATES
  • Table 22: USA Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by Stents - Coronary Stents, PTCA Catheters and Coronary Guidedwires - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 23: USA Historic Review for Percutaneous Coronary Intervention (PCI) Devices by Stents - Coronary Stents, PTCA Catheters and Coronary Guidedwires Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 24: USA 15-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by Stents - Percentage Breakdown of Value Sales for Coronary Stents, PTCA Catheters and Coronary Guidedwires for the Years 2012, 2020 & 2027
  • Table 25: USA Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Hospitals, Ambulatory Surgical Centers and Catheterization Labs - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 26: USA Historic Review for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Hospitals, Ambulatory Surgical Centers and Catheterization Labs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 27: USA 15-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgical Centers and Catheterization Labs for the Years 2012, 2020 & 2027
  • CANADA
  • Table 28: Canada Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by Stents - Coronary Stents, PTCA Catheters and Coronary Guidedwires - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 29: Canada Historic Review for Percutaneous Coronary Intervention (PCI) Devices by Stents - Coronary Stents, PTCA Catheters and Coronary Guidedwires Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 30: Canada 15-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by Stents - Percentage Breakdown of Value Sales for Coronary Stents, PTCA Catheters and Coronary Guidedwires for the Years 2012, 2020 & 2027
  • Table 31: Canada Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Hospitals, Ambulatory Surgical Centers and Catheterization Labs - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 32: Canada Historic Review for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Hospitals, Ambulatory Surgical Centers and Catheterization Labs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 33: Canada 15-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgical Centers and Catheterization Labs for the Years 2012, 2020 & 2027
  • JAPAN
  • Table 34: Japan Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by Stents - Coronary Stents, PTCA Catheters and Coronary Guidedwires - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 35: Japan Historic Review for Percutaneous Coronary Intervention (PCI) Devices by Stents - Coronary Stents, PTCA Catheters and Coronary Guidedwires Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 36: Japan 15-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by Stents - Percentage Breakdown of Value Sales for Coronary Stents, PTCA Catheters and Coronary Guidedwires for the Years 2012, 2020 & 2027
  • Table 37: Japan Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Hospitals, Ambulatory Surgical Centers and Catheterization Labs - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 38: Japan Historic Review for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Hospitals, Ambulatory Surgical Centers and Catheterization Labs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 39: Japan 15-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgical Centers and Catheterization Labs for the Years 2012, 2020 & 2027
  • CHINA
  • Table 40: China Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by Stents - Coronary Stents, PTCA Catheters and Coronary Guidedwires - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 41: China Historic Review for Percutaneous Coronary Intervention (PCI) Devices by Stents - Coronary Stents, PTCA Catheters and Coronary Guidedwires Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 42: China 15-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by Stents - Percentage Breakdown of Value Sales for Coronary Stents, PTCA Catheters and Coronary Guidedwires for the Years 2012, 2020 & 2027
  • Table 43: China Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Hospitals, Ambulatory Surgical Centers and Catheterization Labs - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 44: China Historic Review for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Hospitals, Ambulatory Surgical Centers and Catheterization Labs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 45: China 15-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgical Centers and Catheterization Labs for the Years 2012, 2020 & 2027
  • EUROPE
  • Table 46: Europe Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 47: Europe Historic Review for Percutaneous Coronary Intervention (PCI) Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 48: Europe 15-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027
  • Table 49: Europe Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by Stents - Coronary Stents, PTCA Catheters and Coronary Guidedwires - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 50: Europe Historic Review for Percutaneous Coronary Intervention (PCI) Devices by Stents - Coronary Stents, PTCA Catheters and Coronary Guidedwires Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 51: Europe 15-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by Stents - Percentage Breakdown of Value Sales for Coronary Stents, PTCA Catheters and Coronary Guidedwires for the Years 2012, 2020 & 2027
  • Table 52: Europe Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Hospitals, Ambulatory Surgical Centers and Catheterization Labs - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 53: Europe Historic Review for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Hospitals, Ambulatory Surgical Centers and Catheterization Labs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 54: Europe 15-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgical Centers and Catheterization Labs for the Years 2012, 2020 & 2027
  • FRANCE
  • Table 55: France Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by Stents - Coronary Stents, PTCA Catheters and Coronary Guidedwires - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 56: France Historic Review for Percutaneous Coronary Intervention (PCI) Devices by Stents - Coronary Stents, PTCA Catheters and Coronary Guidedwires Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 57: France 15-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by Stents - Percentage Breakdown of Value Sales for Coronary Stents, PTCA Catheters and Coronary Guidedwires for the Years 2012, 2020 & 2027
  • Table 58: France Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Hospitals, Ambulatory Surgical Centers and Catheterization Labs - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 59: France Historic Review for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Hospitals, Ambulatory Surgical Centers and Catheterization Labs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 60: France 15-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgical Centers and Catheterization Labs for the Years 2012, 2020 & 2027
  • GERMANY
  • Table 61: Germany Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by Stents - Coronary Stents, PTCA Catheters and Coronary Guidedwires - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 62: Germany Historic Review for Percutaneous Coronary Intervention (PCI) Devices by Stents - Coronary Stents, PTCA Catheters and Coronary Guidedwires Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 63: Germany 15-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by Stents - Percentage Breakdown of Value Sales for Coronary Stents, PTCA Catheters and Coronary Guidedwires for the Years 2012, 2020 & 2027
  • Table 64: Germany Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Hospitals, Ambulatory Surgical Centers and Catheterization Labs - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 65: Germany Historic Review for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Hospitals, Ambulatory Surgical Centers and Catheterization Labs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 66: Germany 15-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgical Centers and Catheterization Labs for the Years 2012, 2020 & 2027
  • ITALY
  • Table 67: Italy Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by Stents - Coronary Stents, PTCA Catheters and Coronary Guidedwires - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 68: Italy Historic Review for Percutaneous Coronary Intervention (PCI) Devices by Stents - Coronary Stents, PTCA Catheters and Coronary Guidedwires Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 69: Italy 15-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by Stents - Percentage Breakdown of Value Sales for Coronary Stents, PTCA Catheters and Coronary Guidedwires for the Years 2012, 2020 & 2027
  • Table 70: Italy Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Hospitals, Ambulatory Surgical Centers and Catheterization Labs - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 71: Italy Historic Review for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Hospitals, Ambulatory Surgical Centers and Catheterization Labs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 72: Italy 15-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgical Centers and Catheterization Labs for the Years 2012, 2020 & 2027
  • UNITED KINGDOM
  • Table 73: UK Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by Stents - Coronary Stents, PTCA Catheters and Coronary Guidedwires - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 74: UK Historic Review for Percutaneous Coronary Intervention (PCI) Devices by Stents - Coronary Stents, PTCA Catheters and Coronary Guidedwires Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 75: UK 15-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by Stents - Percentage Breakdown of Value Sales for Coronary Stents, PTCA Catheters and Coronary Guidedwires for the Years 2012, 2020 & 2027
  • Table 76: UK Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Hospitals, Ambulatory Surgical Centers and Catheterization Labs - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 77: UK Historic Review for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Hospitals, Ambulatory Surgical Centers and Catheterization Labs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 78: UK 15-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgical Centers and Catheterization Labs for the Years 2012, 2020 & 2027
  • REST OF EUROPE
  • Table 79: Rest of Europe Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by Stents - Coronary Stents, PTCA Catheters and Coronary Guidedwires - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 80: Rest of Europe Historic Review for Percutaneous Coronary Intervention (PCI) Devices by Stents - Coronary Stents, PTCA Catheters and Coronary Guidedwires Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 81: Rest of Europe 15-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by Stents - Percentage Breakdown of Value Sales for Coronary Stents, PTCA Catheters and Coronary Guidedwires for the Years 2012, 2020 & 2027
  • Table 82: Rest of Europe Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Hospitals, Ambulatory Surgical Centers and Catheterization Labs - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 83: Rest of Europe Historic Review for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Hospitals, Ambulatory Surgical Centers and Catheterization Labs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 84: Rest of Europe 15-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgical Centers and Catheterization Labs for the Years 2012, 2020 & 2027
  • ASIA-PACIFIC
  • Table 85: Asia-Pacific Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by Stents - Coronary Stents, PTCA Catheters and Coronary Guidedwires - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 86: Asia-Pacific Historic Review for Percutaneous Coronary Intervention (PCI) Devices by Stents - Coronary Stents, PTCA Catheters and Coronary Guidedwires Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 87: Asia-Pacific 15-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by Stents - Percentage Breakdown of Value Sales for Coronary Stents, PTCA Catheters and Coronary Guidedwires for the Years 2012, 2020 & 2027
  • Table 88: Asia-Pacific Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Hospitals, Ambulatory Surgical Centers and Catheterization Labs - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 89: Asia-Pacific Historic Review for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Hospitals, Ambulatory Surgical Centers and Catheterization Labs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 90: Asia-Pacific 15-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgical Centers and Catheterization Labs for the Years 2012, 2020 & 2027
  • REST OF WORLD
  • Table 91: Rest of World Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by Stents - Coronary Stents, PTCA Catheters and Coronary Guidedwires - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 92: Rest of World Historic Review for Percutaneous Coronary Intervention (PCI) Devices by Stents - Coronary Stents, PTCA Catheters and Coronary Guidedwires Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 93: Rest of World 15-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by Stents - Percentage Breakdown of Value Sales for Coronary Stents, PTCA Catheters and Coronary Guidedwires for the Years 2012, 2020 & 2027
  • Table 94: Rest of World Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Hospitals, Ambulatory Surgical Centers and Catheterization Labs - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 95: Rest of World Historic Review for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Hospitals, Ambulatory Surgical Centers and Catheterization Labs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 96: Rest of World 15-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgical Centers and Catheterization Labs for the Years 2012, 2020 & 2027

IV. COMPETITION
  • Total Companies Profiled: 44
Note: Product cover images may vary from those shown